Candel Therapeutics Inc (CADL)
9.02
+0.59
(+7.00%)
USD |
NASDAQ |
May 03, 16:00
8.95
-0.07
(-0.78%)
After-Hours: 20:00
Candel Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2022 | 0.437 |
| September 30, 2022 | 0.398 |
| June 30, 2022 | 0.3434 |
| March 31, 2022 | 0.3219 |
| December 31, 2021 | 0.0087 |
| Date | Value |
|---|---|
| September 30, 2021 | 0.0086 |
| June 30, 2021 | -0.0121 |
| March 31, 2021 | -0.0351 |
| December 31, 2020 | -0.0401 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.0401
Minimum
Dec 2020
0.437
Maximum
Dec 2022
0.1589
Average
0.0087
Median
Dec 2021
Debt to Equity Ratio Benchmarks
| Allurion Technologies Inc | -0.5482 |
| AngioDynamics Inc | 0.00 |
| Eliem Therapeutics Inc | -- |
| Macrogenics Inc | 0.00 |
| GlycoMimetics Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 41.20M |
| Total Liabilities (Quarterly) | 28.46M |
| Shareholders Equity (Quarterly) | 12.74M |